NCT01329796View on ClinicalTrials.gov

Pertubation With Lignocaine in Endometriosis

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

March 31, 2010

Conditions
EndometriosisDysmenorrhea
Interventions
DRUG

Lignocaine

Intrauterine flushing, pertubation, three treatments given preovulatory at cycle day 6-12 in three sequential menstrual cycles.

DRUG

Ringers Solution

Intrauterine flushing, pertubation, given preovulatory at cycle day 6-12 in three sequential menstrual cycles.

Trial Locations (3)

118 72

Läkargruppen Victoria Söderhallarna 120, Stockholm

141 86

Karolinska Institute, Fertility Unit, K59 Karolinska University Hospital at Huddinge, Stockholm

182 88

Department of Gynaecology and Obstetrics Danderyd Hospital, Stockholm

All Listed Sponsors
collaborator

Region Stockholm

OTHER_GOV

lead

Isifer AB

INDUSTRY

NCT01329796 - Pertubation With Lignocaine in Endometriosis | Biotech Hunter | Biotech Hunter